Evidence map›Paper›PMID 37395395›Full record

ArticleNucleic acids research2023

ZMYM2 is essential for methylation of germline genes and active transposons in embryonic development.

Adda-Lee Graham-Paquin, Deepak Saini, Jacinthe Sirois, Ishtiaque Hossain, Megan S Katz, Qinwei Kim-Wee Zhuang, Sin Young Kwon, Yojiro Yamanaka, Guillaume Bourque, Maxime Bouchard and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Targeting theBiomedicines · 2025
    Article
  10. Article
  11. Transposons disrupt genomic stability and trigger cancers.Frontiers in cellular and infection microbiology · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. A maternal-effectGenes & development · 2024
    Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Adda-Lee Graham-PaquinDepartment of Biochemistry, McGill University, Montreal, Quebec, Canada.
Deepak SainiDepartment of Biochemistry, McGill University, Montreal, Quebec, Canada.
Jacinthe SiroisDepartment of Biochemistry, McGill University, Montreal, Quebec, Canada.
Ishtiaque HossainDepartment of Biochemistry, McGill University, Montreal, Quebec, Canada.ORCID 0000-0002-4494-0366
Megan S KatzDepartment of Biochemistry, McGill University, Montreal, Quebec, Canada.
Qinwei Kim-Wee ZhuangDepartment of Human Genetics, McGill University, Montreal, Quebec, Canada.
Sin Young KwonDepartment of Biochemistry, McGill University, Montreal, Quebec, Canada.
Yojiro YamanakaThe Rosalind & Morris Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada.ORCID 0000-0003-1483-8691
Guillaume BourqueDepartment of Human Genetics, McGill University, Montreal, Quebec, Canada.ORCID 0000-0002-3933-9656
Maxime BouchardDepartment of Biochemistry, McGill University, Montreal, Quebec, Canada.
William A PastorDepartment of Biochemistry, McGill University, Montreal, Quebec, Canada.ORCID 0000-0003-4176-5299
McGill University · CA

Funding

CIHR PJG-183984CIHR PJT-159768CIHR PJT-166169
6 · The paper itself

Abstract

ZMYM2 is a transcriptional repressor whose role in development is largely unexplored. We found that Zmym2-/- mice show embryonic lethality by E10.5. Molecular characterization of Zmym2-/- embryos revealed two distinct defects. First, they fail to undergo DNA methylation and silencing of germline gene promoters, resulting in widespread upregulation of germline genes. Second, they fail to methylate and silence the evolutionarily youngest and most active LINE element subclasses in mice. Zmym2-/- embryos show ubiquitous overexpression of LINE-1 protein as well as aberrant expression of transposon-gene fusion transcripts. ZMYM2 homes to sites of PRC1.6 and TRIM28 complex binding, mediating repression of germline genes and transposons respectively. In the absence of ZMYM2, hypermethylation of histone 3 lysine 4 occurs at target sites, creating a chromatin landscape unfavourable for establishment of DNA methylation. ZMYM2-/- human embryonic stem cells also show aberrant upregulation and demethylation of young LINE elements, indicating a conserved role in repression of active transposons. ZMYM2 is thus an important new factor in DNA methylation patterning in early embryonic development.

Indexed as

DNA MethylationAnimalsChromatinDNA-Binding ProteinsEmbryonic DevelopmentGerm CellsHistonesHumansMiceTranscription FactorsChromatinDNA-Binding ProteinsHistonesTranscription FactorsZMYM2 protein, humanZmym2 protein, mouse

Identifiers

PMID37395395
PMCPMC10415128
OpenAlexW4382918749

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.